2 Bay Area Biotechs That Jumped While Its Peers Cratered Post author:Sam Post published:February 6, 2018 Post category:BioPharma Since Friday, the stock market has been volatile, to say the least. Source: BioSpace You Might Also Like How Gilead Lost $7.8B in October Alone November 2, 2017 Busy Takeda Takes Out Tigenix in $630M Deal January 4, 2018 Epizyme Falls as Investors Take in Disappointing Phase II Data June 14, 2017
